PPARA and COVID-19: PPARγ dysregulation can also be strengthened by the metabolomic and proteomic study analyzing the serum of COVID-19 patients by Yang et al. (2021), who reported that differential metabolites obtained were responsible for the PPAR signaling pathway and differentially expressed proteins (DEPs) were involved in NF-kappa B signaling pathway, respectively [27].